ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,079Medicare Part D Prescriptions Filled, Including Refills

Rank: 238 out of 1121

$642K Total Retail Price of All Prescriptions

Rank: 253 out of 1121

544 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 544 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 544 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 11,549 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
AMLODIPINE BESYLATE 833 811 1 5
SIMVASTATIN 558 545 2 1
FUROSEMIDE 491 476 3 7
LEVOTHYROXINE SODIUM 343 338 4 2
METOPROLOL TARTRATE 291 276 5 9
HYDROCHLOROTHIAZIDE 267 261 6 10
LOSARTAN POTASSIUM 248 244 7 17
OMEPRAZOLE 241 225 8 6
POTASSIUM CHLORIDE 238 233 9 12
TRIAMTERENE-HCTZ 227 219 10 38
LISINOPRIL 215 205 11 4
WARFARIN SODIUM 202 202 12 11
SOTALOL 193 193 13 199
HYDROCODONE-ACETAMINOPHEN 175 174 S3 14 3
CLOPIDOGREL 172 171 15 27
TAMSULOSIN HCL 166 166 16 32
ALLOPURINOL 161 152 17 30
CARVEDILOL 160 156 18 20
METFORMIN HCL 159 134 19 8
METOPROLOL SUCCINATE 155 140 20 23
PLAVIX 154 154 21 42
ZOLPIDEM TARTRATE 144 119 22 19
SYNTHROID 136 136 23 55
CRESTOR 132 128 24 28
TRAMADOL HCL 130 123 25 25
GABAPENTIN 113 106 26 13
NEXIUM 104 104 27 24
DIGOXIN 104 104 27 59
ATORVASTATIN CALCIUM 103 99 29 15
ISOSORBIDE MONONITRATE ER 102 100 30 62
CEFUROXIME 101 100 31 163
GLYBURIDE 98 88 R 32 51
KLOR-CON 10 95 91 33 69
CITALOPRAM HBR 94 84 34 18
DIOVAN 85 85 35 45
DONEPEZIL HCL 83 83 36 35
ATENOLOL 82 82 37 16
FELODIPINE ER 72 61 38 169
MELOXICAM 70 55 39 22
VYTORIN 70 70 39 195
PANTOPRAZOLE SODIUM 69 69 41 29
BENICAR 68 64 42 176
FAMOTIDINE 68 68 42 63
SPIRONOLACTONE 68 67 42 54
SPIRIVA 67 67 45 49
SERTRALINE HCL 66 64 46 21
LEVOFLOXACIN 64 62 47 79
ZETIA 63 55 48 80
ESCITALOPRAM OXALATE 63 63 48 94
CLONIDINE HCL 62 58 50 39
NIFEDIPINE ER 58 54 51 102
DOXAZOSIN MESYLATE 57 53 52 93
LYRICA 56 51 53 76
FLUTICASONE PROPIONATE 55 55 54 36
HYDRALAZINE HCL 55 55 54 66
AMITRIPTYLINE HCL 55 51 R 54 61
CIPROFLOXACIN HCL 55 53 54 57
MECLIZINE HCL 53 53 58 115
SINGULAIR 51 51 59 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.